{
    "root": "30f6c6b2-4633-4cf9-b316-eb4f301a355f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Linezolid",
    "value": "20250327",
    "ingredients": [
        {
            "name": "LINEZOLID",
            "code": "ISQ9I6J12J"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLACRILIN POTASSIUM",
            "code": "0BZ5A00FQU"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        }
    ],
    "indications": "linezolid indicated treatment infections caused susceptible strains designated microorganisms conditions listed . linezolid indicated treatment gram-negative infections . critical gram-negative therapy initiated immediately concomitant gram-negative pathogen documented suspected [ ( 5.4 ) ] .",
    "contraindications": ", route , frequency infection pediatric patients ( birth 11 years age ) adults adolescents ( 12 years older ) duration ( days ) nosocomial pneumonia 10 mg/kg intravenous oral every 8 hours 600 mg intravenous oral every 12 hours 10 14 community-acquired pneumonia , including concurrent bacteremia complicated skin skin structure infections vancomycin-resistant enterococcus faecium infections , including concurrent bacteremia 10 mg/kg intravenous oral every 8 hours 600 mg intravenous oral every 12 hours 14 28 uncomplicated skin skin structure infections less 5 yrs : 10 mg/kg oral every 8 hours 5-11 yrs : 10 mg/kg oral every 12 hours adults : 400 mg oral every 12 hours adolescents : 600 mg oral every 12 hours 10 14",
    "warningsAndPrecautions": "16.2 tablets linezolid tablets , 600 mg white white , oval shaped , bevel edged , biconvex film coated tablets , debossed ‘ ’ one side ‘ 22 ’ side . ndc 63629-8576-1 : 20 tablets bottle 16.4 storage store 20º 25ºc ( 68º 77ºf ) [ usp controlled room temperature ] . protect light . keep bottles tightly closed protect moisture . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "• known hypersensitivity linezolid product components . ( 4.1 ) ; patients taking monoamine oxidase inhibitors ( maoi ) within two weeks taking maoi . ( 4.2 )",
    "indications_original": "Linezolid is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Linezolid is not indicated for the treatment of Gram-negative infections. It is critical that specific Gram-negative therapy be initiated immediately if a concomitant Gram-negative pathogen is documented or suspected [see Warnings and Precautions (5.4)].",
    "contraindications_original": "Dosage, Route, and Frequency of Administration Infection Pediatric Patients (Birth through 11 years of Age) Adults and Adolescents (12 Years and Older) Duration (days) Nosocomial pneumonia 10 mg/kg intravenous or oral every 8 hours 600 mg intravenous or oral every 12 hours 10 to 14 Community-acquired pneumonia, including concurrent bacteremia Complicated skin and skin structure infections Vancomycin-resistant Enterococcus faecium infections, including concurrent bacteremia 10 mg/kg intravenous or oral every 8 hours 600 mg intravenous or oral every 12 hours 14 to 28 Uncomplicated skin and skin structure infections less than 5 yrs: 10 mg/kg oral every 8 hours 5-11 yrs: 10 mg/kg oral every  12 hours Adults: 400 mg oral every 12 hours Adolescents:                     600 mg oral every 12 hours 10 to 14",
    "warningsAndPrecautions_original": "16.2 Tablets\n                  \n                  Linezolid Tablets, 600 mg are white to off white, oval shaped, bevel edged, biconvex film coated tablets, debossed with ‘I’ on one side and ‘22’ on other side.\n                  \n                     NDC 63629-8576-1: 20 Tablets in a BOTTLE\n                  \n                  \n                     16.4 Storage\n                  \n                  Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Protect from light. Keep bottles tightly closed to protect from moisture.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "• Known hypersensitivity to linezolid or any of the other product components. ( 4.1 ); Patients taking any monoamine oxidase inhibitors (MAOI) or within two weeks of taking an MAOI. ( 4.2 )"
}